日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease

血清三叶因子-3可预测外周动脉疾病患者的生存率

Pesau, Gerfried; Zierfuss, Bernhard; Hoebaus, Clemens; Koppensteiner, Renate; Schernthaner, Gerit-Holger

Prevalence of extracranial carotid artery disease in symptomatic peripheral artery disease and implications for long-term outcome

症状性外周动脉疾病患者中颅外颈动脉疾病的患病率及其对长期预后的影响

Zierfuss, Bernhard; Witt-Dörring, Ladislaja; Ceschi A Santa Croce, Anna; Hannes, Antonia; Staudacher, Moritz; Pesau, Gerfried; Schlager, Oliver; Gschwandtner, Michael; Schernthaner, Gerit-Holger; Höbaus, Clemens

Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.

血管生成素——一种被提议作为心血管疾病生物标志物的物质——与外周动脉疾病患者的长期生存率无关

Höbaus Clemens, Pesau Gerfried, Zierfuss Bernhard, Koppensteiner Renate, Schernthaner Gerit-Holger

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes

血小板反应蛋白-4水平随外周动脉疾病严重程度的加重而升高,且与糖尿病相关。

Zierfuss, Bernhard; Höbaus, Clemens; Herz, Carsten T; Pesau, Gerfried; Koppensteiner, Renate; Schernthaner, Gerit-Holger

To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study"

致编辑:关于文章“在糖尿病足患者中,与单独使用 DPP-4 抑制剂相比,DPP-4 抑制剂与胰岛素联合治疗并不能进一步降低心血管事件的风险:一项全国性人群研究”

Mayer, Florian J; Pesau, Gerfried; Schernthaner, Gerit H